Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke

In 1995, the NINDS (National Institute of Neurological Disorders and Stroke) tPA (tissue plasminogen activator) Stroke Study Group published the results of a large multicenter clinical trial demonstrating efficacy of intravenous tPA by revealing a 30% relative risk reduction (absolute risk reduction...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Chapman, Sherita N, Mehndiratta, Prachi, Johansen, Michelle C, McMurry, Timothy L, Johnston, Karen C, Southerland, Andrew M
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2014
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3938499/
https://ncbi.nlm.nih.gov/pubmed/24591838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S39213
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items